13 reports

Zocor is a statin and reduces the risk of stroke, heart attack, and other heart complications in individuals with diabetes, coronary heart diseases, or other risk factors.

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC
  • Clinical Trial profile. 129 Trial Title
  • Clinical Trial profile. 198 Trial Title

Coronary Disease clinical trial report consists of ## trials.

  • Pharmaceutical
  • Salicylic Acid
  • Statins
  • World
  • Product Initiative
  • Official Title
  • Clinical Trial profile. 437 Trial Title

ETUse of a Genetic Risk Score to Predict Coronary and Vascular Events and Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease From the FOURIER TrialSunday, Nov. ##, ##:##-##:## a. m.

  • Cardiovascular Disease
  • Clinical Trial
  • Drug Development
  • Statins
  • World
  • Clinical Trial profile. 75 Trial Title
  • Clinical Trial profile. 323 Trial Title

(SHARP) GDCT## NCT##, U##-##-##; SKNMC& GH-HS/ ##/ 2016; ISRCTN##; CTRI/ 2018/ ##/ ## Cardiovascular Atherosclerosis, Cerebrovascular Disease, Coronary Artery Disease (CAD) (Ischemic Heart Disease), Deep Vei

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World
  • Clinical Trial profile. 98 Trial Title
  • 5. All the trials included are unique trials.

CSP Metabolic Disorders Atherosclerosis, Coronary Artery Disease (CAD) (Ischemic Heart Disease), Heterozygous familial hypercholesterolemia (heFH), Homozygous Familial Hypercholesterolemia (HoFH), Hypercholesterolemia, Hyperlipidemia, Myocardial Infarction Ongoing

  • Cardiovascular Disease
  • Clinical Trial
  • Statins
  • Therapy
  • World
  • Target
  • Target

A Study of Management Using Relaxation Techniques The effect of mental stress on the heart in patients with coronary artery disease.

  • Clinical Trial
  • Drug Development
  • Statins
  • World
  • Merck & Co., Inc.
  • Clinical Trial profile. 787 Trial Title
  • 5. All the trials included are unique trials.

## ## A Phase IIIb, Multi-center, Double-blind, Placebo-controlled, Parallel Group, Study to Evaluate the Effect of Dalcetrapib ## mg on Cardiovascular (CV) Events in Adult Patients with Stable Coronary Heart Disease (CHD), CHD Risk Equivalents or at Elevated Risk

  • Clinical Trial
  • Lipid Modifying Drug
  • Pharmaceutical
  • Statins
  • World
  • DYSLIPIDEMIA - PIPELINE BY YUHAN CORP, H1 2020

The company offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases.

  • Cholesterol
  • Digestive System Disorder
  • Pharmaceutical
  • Statins
  • Amarin Corporation plc
  • DYSLIPIDEMIA - PIPELINE BY YUHAN CORP, H2 2019

The company offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases.

  • Cholesterol
  • Chronic Disease
  • Pharmaceutical
  • Statins
  • Amarin Corporation plc
  • Target
  • Clinical Trial profile. 260 Trial Title

One to three weeks after the last infusion, they underwent a second ultrasound examination of the same coronary artery that had previously been shown to be at least ## percent blocked.

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World

The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.

  • Cardiovascular Disease
  • Clinical Trial
  • Statins
  • World
  • Product Initiative
  • Target
  • Clinical Trial profile. 260 Trial Title

High-dose Pitavastatin on In-stent Restenosis, Endothelial Function, Circulating microRNAs, and Cardiovascular Events in Patients with Coronary Artery Disease Requiring Stent Implantation: OCT and NIRS Comparison Effect of Low-dose vs.

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World
  • HYPERLIPIDEMIA - PIPELINE BY YUHAN CORPORATION, H1 2016

It offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases.

  • Endocrine Disease
  • Statins
  • United States
  • Company
  • Product Initiative